BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 15314077)

  • 1. Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia.
    Messmer BT; Albesiano E; Efremov DG; Ghiotto F; Allen SL; Kolitz J; Foa R; Damle RN; Fais F; Messmer D; Rai KR; Ferrarini M; Chiorazzi N
    J Exp Med; 2004 Aug; 200(4):519-25. PubMed ID: 15314077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGHV1-69 B cell chronic lymphocytic leukemia antibodies cross-react with HIV-1 and hepatitis C virus antigens as well as intestinal commensal bacteria.
    Hwang KK; Trama AM; Kozink DM; Chen X; Wiehe K; Cooper AJ; Xia SM; Wang M; Marshall DJ; Whitesides J; Alam M; Tomaras GD; Allen SL; Rai KR; McKeating J; Catera R; Yan XJ; Chu CC; Kelsoe G; Liao HX; Chiorazzi N; Haynes BF
    PLoS One; 2014; 9(3):e90725. PubMed ID: 24614505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silenced B-cell receptor response to autoantigen in a poor-prognostic subset of chronic lymphocytic leukemia.
    Bergh AC; Evaldsson C; Pedersen LB; Geisler C; Stamatopoulos K; Rosenquist R; Rosén A
    Haematologica; 2014 Nov; 99(11):1722-30. PubMed ID: 25085355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological and clinical significance of stereotyped B-cell receptors in chronic lymphocytic leukemia.
    Rossi D; Gaidano G
    Haematologica; 2010 Dec; 95(12):1992-5. PubMed ID: 21123439
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification and validation of biomarkers of IgV(H) mutation status in chronic lymphocytic leukemia using microfluidics quantitative real-time polymerase chain reaction technology.
    Abruzzo LV; Barron LL; Anderson K; Newman RJ; Wierda WG; O'brien S; Ferrajoli A; Luthra M; Talwalkar S; Luthra R; Jones D; Keating MJ; Coombes KR
    J Mol Diagn; 2007 Sep; 9(4):546-55. PubMed ID: 17690214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor revision of immunoglobulin heavy chain variable region genes in normal human B lymphocytes.
    Wilson PC; Wilson K; Liu YJ; Banchereau J; Pascual V; Capra JD
    J Exp Med; 2000 Jun; 191(11):1881-94. PubMed ID: 10839804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-cell receptor immunoglobulin stereotypy in chronic lymphocytic leukemia: Key to understanding disease biology and stratifying patients.
    Agathangelidis A; Chatzikonstantinou T; Stamatopoulos K
    Semin Hematol; 2024 Apr; 61(2):91-99. PubMed ID: 38242773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic approach for peptide characterization of B-cell receptor in chronic lymphocytic leukemia cells.
    Díez P; Ibarrola N; Dégano RM; Lécrevisse Q; Rodriguez-Caballero A; Criado I; Nieto WG; Góngora R; González M; Almeida J; Orfao A; Fuentes M
    Oncotarget; 2017 Jun; 8(26):42836-42846. PubMed ID: 28467808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inferring B Cell Phylogenies from Paired H and L Chain BCR Sequences with Dowser.
    Jensen CG; Sumner JA; Kleinstein SH; Hoehn KB
    J Immunol; 2024 May; 212(10):1579-1588. PubMed ID: 38557795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Massively parallel single-cell B-cell receptor sequencing enables rapid discovery of diverse antigen-reactive antibodies.
    Goldstein LD; Chen YJ; Wu J; Chaudhuri S; Hsiao YC; Schneider K; Hoi KH; Lin Z; Guerrero S; Jaiswal BS; Stinson J; Antony A; Pahuja KB; Seshasayee D; Modrusan Z; Hötzel I; Seshagiri S
    Commun Biol; 2019; 2():304. PubMed ID: 31428692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Language model-based B cell receptor sequence embeddings can effectively encode receptor specificity.
    Wang M; Patsenker J; Li H; Kluger Y; Kleinstein SH
    Nucleic Acids Res; 2024 Jan; 52(2):548-557. PubMed ID: 38109302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies.
    Agathangelidis A; Darzentas N; Hadzidimitriou A; Brochet X; Murray F; Yan XJ; Davis Z; van Gastel-Mol EJ; Tresoldi C; Chu CC; Cahill N; Giudicelli V; Tichy B; Pedersen LB; Foroni L; Bonello L; Janus A; Smedby K; Anagnostopoulos A; Merle-Beral H; Laoutaris N; Juliusson G; di Celle PF; Pospisilova S; Jurlander J; Geisler C; Tsaftaris A; Lefranc MP; Langerak AW; Oscier DG; Chiorazzi N; Belessi C; Davi F; Rosenquist R; Ghia P; Stamatopoulos K
    Blood; 2012 May; 119(19):4467-75. PubMed ID: 22415752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cells generated by B-1 development can progress to chronic lymphocytic leukemia.
    Hayakawa K; Formica AM; Colombo MJ; Ichikawa D; Shinton SA; Brill-Dashoff J; Hardy RR
    Ann N Y Acad Sci; 2015 Dec; 1362():250-5. PubMed ID: 25907284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis.
    Murray F; Darzentas N; Hadzidimitriou A; Tobin G; Boudjogra M; Scielzo C; Laoutaris N; Karlsson K; Baran-Marzsak F; Tsaftaris A; Moreno C; Anagnostopoulos A; Caligaris-Cappio F; Vaur D; Ouzounis C; Belessi C; Ghia P; Davi F; Rosenquist R; Stamatopoulos K
    Blood; 2008 Feb; 111(3):1524-33. PubMed ID: 17959859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations.
    Stamatopoulos K; Belessi C; Moreno C; Boudjograh M; Guida G; Smilevska T; Belhoul L; Stella S; Stavroyianni N; Crespo M; Hadzidimitriou A; Sutton L; Bosch F; Laoutaris N; Anagnostopoulos A; Montserrat E; Fassas A; Dighiero G; Caligaris-Cappio F; Merle-Béral H; Ghia P; Davi F
    Blood; 2007 Jan; 109(1):259-70. PubMed ID: 16985177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.
    Hallek M; Cheson BD; Catovsky D; Caligaris-Cappio F; Dighiero G; Döhner H; Hillmen P; Keating MJ; Montserrat E; Rai KR; Kipps TJ;
    Blood; 2008 Jun; 111(12):5446-56. PubMed ID: 18216293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.
    Fais F; Ghiotto F; Hashimoto S; Sellars B; Valetto A; Allen SL; Schulman P; Vinciguerra VP; Rai K; Rassenti LZ; Kipps TJ; Dighiero G; Schroeder HW; Ferrarini M; Chiorazzi N
    J Clin Invest; 1998 Oct; 102(8):1515-25. PubMed ID: 9788964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of prognostic markers in patients with CLL.
    Braish J; Cerchione C; Ferrajoli A
    Front Oncol; 2024; 14():1371057. PubMed ID: 38817892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chinese expert consensus on Bruton tyrosine kinase inhibitors in the treatment of B-cell malignancies.
    Song Y; Wu SJ; Shen Z; Zhao D; Chan TSY; Huang H; Qiu L; Li J; Tan TD; Zhu J; Song Y; Huang WH; Zhao W; Liu HSY; Xu W; Chen N; Ma J; Chang CS; Tse EWC
    Exp Hematol Oncol; 2023 Oct; 12(1):92. PubMed ID: 37845755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B Cell Chronic Lymphocytic Leukemia Development in Mice with Chronic Lung Exposure to Coccidioides Fungal Arthroconidia.
    Coyne V; Mead HL; Mongini PKA; Barker BM
    Immunohorizons; 2023 May; 7(5):333-352. PubMed ID: 37195872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.